Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:17 PM
Ignite Modification Date: 2025-12-24 @ 7:17 PM
NCT ID: NCT01932203
Eligibility Criteria: Inclusion Criteria: * 50 to 85 years of age * He/She can walk to the hospital (walker or cane is permissible). * Cerebral small vessel disease is observed on brain MRI. 1\) presence of one or more lacunar infarction and 2) moderate or severe confluent leukoaraiosis (defined as grade 2 or 3 on a modified Fazekas scale): periventricular WMCs with cap or rims lager than 5mm and deep subcortical WMCs \>10 mm in maximum diameter * written informed consent Exclusion Criteria: * Any patient with contraindication of antiplatelets * Any patient with cardioembolic source * Carotid bruit or large cerebral artery stenosis \>50% * Cortical infarction or subcortical infarction lager than 1.5 cm * bleeding tendency * chronic liver disease (AST or ALT \>100 IL/L) * chronic renal disease (Creatinine \>3.0mg/dL) * active gastrointestinal ulcer * any patients with any severe or unstable medical disease that may prevent them from completing study requirements (i.e., unstable or severe asthma) * Anemia (Hb \<10g/dL) or thrombocytopenia * Cardiac pacemaker or contraindication to MRI * Pregnancy or breast-feeding * drug or alcohol addiction * Any other white matte disease (i.e., Multiple sclerosis, sarcoidosis, or brain irradiation, etc) or brain tumor * Parkinson's disease, Alzheimer's disease or any other neurodegenerative disease * any hearing or visual impairment that can disturb the efficient evaluation of the patient * recent cerebral infarction with 3 months
Healthy Volunteers: False
Sex: ALL
Minimum Age: 50 Years
Maximum Age: 85 Years
Study: NCT01932203
Study Brief:
Protocol Section: NCT01932203